menu
    • menu
    [{"orgOrder":0,"company":"Merro Pharmaceutical","sponsor":"Merro Pharmaceutical","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"CHINA","productType":"Miscellaneous","year":"2013","type":"Inapplicable","leadProduct":"Amifostine","moa":"phosphoro-derivatives","graph1":"Oncology","graph2":"Phase II","graph3":"Merro Pharmaceutical","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Merro Pharmaceutical \/ Merro Pharmaceutical","highestDevelopmentStatusID":"8","companyTruncated":"Merro Pharmaceutical \/ Merro Pharmaceutical"}]

    Find Clinical Drug Pipeline Developments & Deals by Merro Pharmaceutical

    Menu

    Merro Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Merro Pharmaceutical

                            China arrow
                            Pharmtech & Ingredients
                            Not Confirmed

                            Merro Pharmaceutical

                            China arrow
                            Pharmtech & Ingredients
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Amifostine

                            Therapeutic Area : Oncology

                            Study Phase : Phase II

                            Recipient : Sun Yat-sen University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens

                            Details : Amifostine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Nasopharyngeal Neoplasms.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            January 07, 2013

                            Lead Product(s) : Amifostine

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase II

                            Recipient : Sun Yat-sen University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth